2017
DOI: 10.1016/j.addr.2017.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design

Abstract: As small molecule drugs become harder to develop and less cost effective for patient use, efficient strategies for their property improvement become increasingly important to global health initiatives. Improvements in the physical properties of Active Pharmaceutical Ingredients (APIs), without changes in the covalent chemistry, have long been possible through the application of binary component solids. This was first achieved through the use of pharmaceutical salts, within the last 10-15years with cocrystals a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
205
0
3

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 295 publications
(210 citation statements)
references
References 175 publications
1
205
0
3
Order By: Relevance
“…If at least one of the components is an active pharmaceutical ingredient (API) and if the coformer is pharmaceutically acceptable, then the substance is recognized as pharmaceutical cocrystal. A pharmaceutical cocrystal can offer multiple benefits for physicochemical and biopharmaceutical properties of APIs, such as increased solubility and dissolution rates, improvement of mechanical properties, and stability [13][14][15]. Particularly, cocrystals have exhibited higher, similar or lower solubility compared to the parent API, depending on the nature of the coformer and the solution conditions [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…If at least one of the components is an active pharmaceutical ingredient (API) and if the coformer is pharmaceutically acceptable, then the substance is recognized as pharmaceutical cocrystal. A pharmaceutical cocrystal can offer multiple benefits for physicochemical and biopharmaceutical properties of APIs, such as increased solubility and dissolution rates, improvement of mechanical properties, and stability [13][14][15]. Particularly, cocrystals have exhibited higher, similar or lower solubility compared to the parent API, depending on the nature of the coformer and the solution conditions [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…ADN has failed to see wide‐spread implementation due to issues with processing, hygroscopicity, and thermal stability . As cocrystallization has proved effective at modulating bulk materials properties in various fields including drug delivery, non‐linear optics, organic electronics, and EMs this presents a promising route to balanced EMs while concomitantly redressing ADNs undesirable properties. However, whereas cocrystallization is now widely studied, cocrystallization between neutral and ionic coformers has yet to significantly impact areas outside of pharmaceuticals .…”
Section: Figurementioning
confidence: 99%
“…As cocrystallization has proved effective at modulating bulk materials properties in various fields including drug delivery, non‐linear optics, organic electronics, and EMs this presents a promising route to balanced EMs while concomitantly redressing ADNs undesirable properties. However, whereas cocrystallization is now widely studied, cocrystallization between neutral and ionic coformers has yet to significantly impact areas outside of pharmaceuticals . This may be due to the difficulties in a priori cocrystal design or the added influence of strong coulombic forces arising from ion–ion interactions.…”
Section: Figurementioning
confidence: 99%
“…[3] ADN has failed to see wide-spread implementation due to issues with processing, hygroscopicity,a nd thermal stability. [4] As cocrystallization has proved effective at modulating bulk materials properties in various fields includ-ing drug delivery, [5] non-linear optics, [6] organic electronics, [7] and EMs [8] this presents ap romising route to balanced EMs while concomitantly redressing ADNs undesirable properties. However,w hereas cocrystallization is now widely studied, cocrystallization between neutral and ionic coformers has yet to significantly impact areas outside of pharmaceuticals.…”
mentioning
confidence: 99%
See 1 more Smart Citation